Fingerprint
Dive into the research topics of 'Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy
Deepa Chand, Franziska Mohr, Hugh McMillan, Francis Fonyuy Tukov, Kyle Montgomery, Aaron Kleyn, Rui Sun, Sitra Tauscher-Wisniewski, Petra Kaufmann, Gerd Kullak-Ublick
Research output: Contribution to journal › Article › peer-review
74
Scopus
citations